ATE80307T1 - Verbesserungen im gebrauch oder in bezug auf den gebrauch von egf. - Google Patents

Verbesserungen im gebrauch oder in bezug auf den gebrauch von egf.

Info

Publication number: ATE80307T1
Authority: AT; Austria
Prior art keywords: egf; iron; value; relating; bloodstream
Prior art date: 1986-12-11

Application number

AT87907612T

Other languages

English (en)

Inventor

Thomas James Greer Wilson

David Robert Cambridge L Tivey

Michael Waddington Smith

Peter Stephen James

Timothy John Peters

Kishor Barchand Headstone Raja

Original Assignee

British Tech Group

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-12-11

Filing date

1987-11-24

Publication date

1992-09-15

1986-12-11 Priority claimed from GB868629674A external-priority patent/GB8629674D0/en

1987-06-05 Priority claimed from GB878713169A external-priority patent/GB8713169D0/en

1987-11-24 Application filed by British Tech Group filed Critical British Tech Group

1992-09-15 Application granted granted Critical

1992-09-15 Publication of ATE80307T1 publication Critical patent/ATE80307T1/de

Links

VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 abstract 4
102000009024 Epidermal Growth Factor Human genes 0.000 abstract 3
101800003838 Epidermal growth factor Proteins 0.000 abstract 3
229940116977 epidermal growth factor Drugs 0.000 abstract 3
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
241001465754 Metazoa Species 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 abstract 1
229960003957 dexamethasone Drugs 0.000 abstract 1
229910052742 iron Inorganic materials 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/168—Steroids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/184—Hormones
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Polymers & Plastics (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Food Science & Technology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Husbandry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Inorganic Chemistry (AREA)
Hematology (AREA)
Immunology (AREA)
Reproductive Health (AREA)
Birds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Feed For Specific Animals (AREA)
Fodder In General (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

AT87907612T 1986-12-11 1987-11-24 Verbesserungen im gebrauch oder in bezug auf den gebrauch von egf. ATE80307T1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB868629674A GB8629674D0 (en)	1986-12-11	1986-12-11	Promotion of animal growth
GB878713169A GB8713169D0 (en)	1987-06-05	1987-06-05	Uptake of iron by body
EP87907612A EP0292517B1 (de)	1986-12-11	1987-11-24	Verbesserungen im gebrauch oder in bezug auf den gebrauch von egf
PCT/GB1987/000839 WO1988004180A1 (en)	1986-12-11	1987-11-24	Improvements in or relating to the use of epidermal growth factor

Publications (1)

Publication Number	Publication Date
ATE80307T1 true ATE80307T1 (de)	1992-09-15

Family

ID=26291686

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT87907612T ATE80307T1 (de)	1986-12-11	1987-11-24	Verbesserungen im gebrauch oder in bezug auf den gebrauch von egf.

Country Status (10)

Country	Link
EP (1)	EP0292517B1 (de)
JP (1)	JPH01501707A (de)
AT (1)	ATE80307T1 (de)
AU (1)	AU620797B2 (de)
CA (1)	CA1315677C (de)
DE (1)	DE3781682T2 (de)
DK (1)	DK447488A (de)
GB (1)	GB2198351B (de)
NZ (1)	NZ222867A (de)
WO (1)	WO1988004180A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5149691A (en) *	1991-03-12	1992-09-22	Creative Biomolecules, Inc.	Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone
US5753622A (en) *	1995-05-10	1998-05-19	University Technologies International, Inc.	Use of epidermal growth factor as a gastrointestinal therapeutic agent
JP2004536589A (ja)	2001-05-18	2004-12-09	カナダ国	ウシ上皮成長因子の核酸及びタンパク質配列
US20160296536A1 (en) *	2015-04-13	2016-10-13	Animal Biotech, LLC	Administration of Glucocorticoid Steroids to Livestock

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3036917A (en) *	1959-11-10	1962-05-29	Upjohn Co	Feeding ruminants 9alpha-fluoro-16alpha-methylprednisolone
US3259500A (en) *	1961-10-11	1966-07-05	Kentucky Res Foundation	Method for inhibiting anemia in young pigs by feeding the sow an iron agent
NO116657B (de) *	1966-11-07	1969-04-28	Ewos Ab
US3737535A (en) *	1971-02-11	1973-06-05	J Brethour	Method of fattening beef cattle
JPS6028999A (ja) *	1983-06-30	1985-02-14	Maruho Kk	細胞増殖促進作用を有するたんぱく質、その組成物と製造方法
GB8409960D0 (en) *	1984-04-17	1984-05-31	Searle & Co	Therapeutic method

1987
- 1987-11-24 EP EP87907612A patent/EP0292517B1/de not_active Expired - Lifetime
- 1987-11-24 DE DE8787907612T patent/DE3781682T2/de not_active Expired - Fee Related
- 1987-11-24 JP JP62507001A patent/JPH01501707A/ja active Pending
- 1987-11-24 WO PCT/GB1987/000839 patent/WO1988004180A1/en not_active Ceased
- 1987-11-24 AU AU82755/87A patent/AU620797B2/en not_active Ceased
- 1987-11-24 AT AT87907612T patent/ATE80307T1/de not_active IP Right Cessation
- 1987-11-24 GB GB8727493A patent/GB2198351B/en not_active Expired - Lifetime
- 1987-12-10 NZ NZ222867A patent/NZ222867A/xx unknown
- 1987-12-10 CA CA000553968A patent/CA1315677C/en not_active Expired - Fee Related
1988
- 1988-08-10 DK DK447488A patent/DK447488A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE3781682T2 (de)	1993-01-21
JPH01501707A (ja)	1989-06-15
DK447488D0 (da)	1988-08-10
EP0292517B1 (de)	1992-09-09
GB8727493D0 (en)	1987-12-23
WO1988004180A1 (en)	1988-06-16
GB2198351A (en)	1988-06-15
CA1315677C (en)	1993-04-06
GB2198351B (en)	1990-07-11
EP0292517A1 (de)	1988-11-30
DK447488A (da)	1988-08-10
DE3781682D1 (de)	1992-10-15
NZ222867A (en)	1990-08-28
AU620797B2 (en)	1992-02-27
AU8275587A (en)	1988-06-30

Similar Documents

Publication	Publication Date	Title
DE69012591D1 (de)	1994-10-27	Verwendung von Nikotin zur Herstellung eines Kit zur Behandlung von Krankheitszuständen, die auf eine Nikotinbehandlung ansprechen.
ATE385810T1 (de)	2008-03-15	Verwendung von dna oder rna zur herstellung eines medikaments zur behandlung von tumoren
MD1432C2 (ro)	2000-09-30	Metodă de tratament al stării dependente de estrogenii ovarieni
ES478967A1 (es)	1980-08-16	Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
ATE80307T1 (de)	1992-09-15	Verbesserungen im gebrauch oder in bezug auf den gebrauch von egf.
ATE191342T1 (de)	2000-04-15	Verwendung von riluzol zur behandlung mitochondrialer erkrankungen
Blanchet et al.	1982	Effects of methyl methacrylate monomer vapors on respiration and circulation in unanesthetized rats
ATE173405T1 (de)	1998-12-15	Arzneimittel auf basis von hyaluronsäure
DE69431430D1 (de)	2002-10-31	Faktor XIII zur Behandlung von Hautwunden
Frey et al.	1947	Depletion of vitamin A reserves in the livers of cattle
Engineer et al.	2023	Comprehensive Review of Jalaukavacharan-Leech Therapy in Purview of Ayurveda
Lekeux et al.	1981	Comparison of different treatments of atrial fibrillation in the horse
SG60292G (en)	1992-09-04	Medical preparation comprising aspoxicillin,a method for its preparation,and the use of such a preparation for the manufacture of a medicament
Bramlage et al.	1982	Evaluation of stainless steel nerve caps for palmar digital neurectomy
DE3877499D1 (de)	1993-02-25	2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
RU94003881A (ru)	1996-06-10	Способ лечения острых респираторных заболеваний у молодняка сельскохозяйственных животных
Jackson	1969	Regrowth of an equine hoof following traumatic removal
GB2019720A (en)	1979-11-07	S-adenosyl-L-homocysteine and salts thereof for use in therapy
Africa	1990	An Act (No. 65 of 1983) to provide for the donation or the making available of human bodies and tissue for the purposes of medical or dental training, research or therapy or the advancement of medicine or dentistry in general; for the post-mortem examination of certain human bodies; for the removal of tissue, blood and gametes from the bodies of living persons and the use thereof for medical or dental purposes; for the control of the artificial insemination of persons; and for the regulation of the import and export of human tissue, blood and gametes; and to provide for matters connected therewith. Date of commencement: 12 July 1985 (the Human Tissue Act, 1983)
Robson	2007	Clostridial diseases in cattle
Marshall et al.	1955	Control of postpartum lochia with kutapressin
Shuttleworth	1988	Systemic contagious pustular dermatitis or orf: Homœopathic treatment of humans, goats and sheep
Catton	1980	A review of the usage of prostaglandins in pigs
Challoner	1960	Orchitis in a Week Old Shetland Colt
Dodd	1945	Painful Intramuscular Injections

Legal Events

Date	Code	Title	Description
1993-05-15	UEP	Publication of translation of european patent specification
1996-08-15	REN	Ceased due to non-payment of the annual fee